We found that p53 had the lowest binding energy, kcal/mol, which indicated that p53 was a key protein for the anti-tumor effect of Juglone, and the foundation to explore the mechanism of Juglone to inhibit the value added of colorectal cancer cells. This evidence concerns the gene TP53 and colorectal cancer.